Arthritis and Lupus Drugs Pulled Off by Pharma Companies

.

Arthritis and Lupus Drugs Pulled Off by Pharma Companies

Following many deaths, rheumatoid arthritis and lupus drugs are being pulled off by Swiss pharmaceutical companies Roche and Biogen. After being observed by monitoring board, the two drugs were found to be immensely infectious and even deadly in some cases.

Ocrelizumab is still reportedly being tested for people who suffer from relapsing remitting multiple sclerosis. The expected sale of 800 million francs is therefore being denied by Roche. Zurich exchange reported a dip of 0.6% at 179.60 Swiss francs in sales of Roche.

Roche had said that before the drug was proved to be causing some serious infections, earlier last year, at the last stage of its trail, was confirmed that it had a powerful impact on curbing the effect of rheumatoid arthritis.

Roche cited a review which said, "The safety risk outweighs the benefits observed in these specific patient populations at this time after detecting serious and opportunistic infections, some of which were fatal".

National Rheumatoid Arthritis Society states that Rheumatoid arthritis is detected in 20 million people and results in stiff, swollen and painful joints after inflation caused by deficiency of immunity.


Latest News

Apple sued by iPhone 6 and iPhone 6 Plus owners affected by ‘Touch Disease’ prob
Apple Watch 2 expected to come with some noteworthy new features
Facebook’s ‘Trending’ section is getting a makeover
Google adds two popular games -- Solitaire and Tic-tac-toe -- to Search
HP Inc. posts better than expected financial results for its fiscal Q3
Tesla announces new Model S and X versions with upgraded battery, super fast acc
Google announces the launch of Android 7.0 ‘Nougat’
Lyft seeking $9B buyout, Uber not willing to pay more than $2B
Recode: Lyft had recently sought $9B in buyout offer
Uber signs $300M deal with Volvo; acquires startup Otto
Instagram introduces new ‘Event Channel’ feature
Ford plans to build a fleet of fully autonomous vehicle by 2021